Clinical Trial Failure Isn’t an Inevitable Risk—It’s Insurable and Opening the Door to New Investors
Clinical trial failure insurance is turning biotech’s most costly risk into a manageable asset, opening new pathways for funding and innovation.
Scott Foster
Advertisement
Managing Director at NFP
Articles by Scott Foster
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
2025 SCRS Global Site Solutions Summit: How Technology Vendors Can Reduce Site Burden and Improve Trial Execution
2
2025 SCRS Global Site Solutions Summit: Best Practices for Building Strong Site Partnerships and Choosing the Right Technology
3
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
4
ACT Brief Weekly Recap: AI Monitoring, Biotech Scaling, and Site Interoperability Lead This Week’s Top Stories
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
